A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer

Clinical trial NCT03735680 · COMPLETED

Trial details

NCT number: NCT03735680
Sponsor: OncoNano Medicine, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Head and Neck Squamous Cell Carcinoma Colorectal Cancer Prostate Cancer Ovarian Cancer Urothelial Carcinoma Non-small Cell Lung Cancer

Start date: 2019-08-09
Primary completion: 2021-10-14
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.